Gilead and Arcus Biosciences Announce Positive Update on Joint TIGIT Program From Interim Analysis of ARC-7 Study in Non-small Cell Lung Cancer Pharmaceutical Investing
VISIONARY-MS Trial Results Featured in Platform Presentation at PACTRIMS 2022: CNM-Au8® Demonstrated Global Neurological Improvement in Stable MS Patients as Adjunct to Background Disease Modifying Therapies Life Science Investing
The Impact of Inaction - New Publication Reveals Not All of Canada is on Track to Meet Global Hepatitis C Elimination Goal Pharmaceutical Investing
Medtronic executives to speak at the Evercore ISI 5th annual HealthCONx conference Medical Device Investing
Sirona Biochem Signs International Partnership Agreement with Wanbang Biopharmaceuticals Life Science Investing
Seelos Therapeutics to Hold a Research and Development Update Conference Call and Webcast on December 15, 2022 Psychedelics Investing
AbbVie Announces European Commission Approval of SKYRIZI® for the Treatment of Moderate to Severe Active Crohn's Disease Pharmaceutical Investing
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
